Specimen Collection Cards Market

Specimen collection cards, also known as sample collection cards or filter paper cards, are specialised paper cards designed to collect and preserve biological samples such as blood, saliva, or urine, for diagnostic testing or research purposes. As these cards are used to simplify sample collection, transportation, and storage, making it easier to analyse samples in a laboratory setting, the market is expected to see 6% growth in revenue over 2023 - 2030.

Specimen collection cards are widely used in medical diagnostics by allowing individuals to provide small samples of their bodily fluids (e.g., blood drops, or saliva) directly onto the card. These cards preserve the samples, preventing degradation and contamination during transport. In the lab, technicians can extract the samples from the cards and perform various tests to diagnose medical conditions or conduct research. However, applications are beyond the medical field, which include forensics, environmental monitoring, and research.

Yes, specimen collection cards offer several advantages, including ease of use, reduced risk of biohazard exposure for healthcare workers, and simplified transportation and storage. They are particularly valuable for collecting samples in remote or resource-limited areas, as they eliminate the need for specialised equipment for sample collection and storage.

Whatman 903 product, a cellulose-based specimen collection card type, has captured the largest market share with its unique design and high-quality materials provide superior sample retention and stability. By material, cotton and cellulose-based materials capture the largest market share for their exceptional absorbent properties that account for their abilities to efficiently collect and preserve biological samples.

PerkinElmer Inc., Danaher Corporation, QIAGEN, DBS System SA, and ARCHIMED Life Science GmbH represent some of the biggest names in the industry.